Trial Outcomes & Findings for Lung Function and Inflammatory Markers in Cement Dust Exposed Workers: A Cross-shifts Study (NCT NCT00727714)

NCT ID: NCT00727714

Last Updated: 2016-05-20

Results Overview

Changes in lung function measurements during one work shift (6-8h), spirometry and gass diffusion capacity

Recruitment status

COMPLETED

Target enrollment

95 participants

Primary outcome timeframe

baseline and 6-8h

Results posted on

2016-05-20

Participant Flow

95 workers from two cement plants in Norway (located in the small cities of in Brevik in South-Norway and Kjøpsvik in the North-Norway) were examined in the winter sesons in 2008 and 2009.

The workers were required to be off work for at least two days before Medical examinations, then exposed to cement Production dust between 0 and 8 h and again between 24 and 32 h. Those not exposed in these periods were excluded. No unexposed controls were included, the participants were their own controls.

Participant milestones

Participant milestones
Measure
Exposed Workers
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Overall Study
STARTED
95
Overall Study
COMPLETED
93
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Exposed Workers
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Overall Study
Lost to Follow-up
2

Baseline Characteristics

Lung Function and Inflammatory Markers in Cement Dust Exposed Workers: A Cross-shifts Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Exposed Workers
n=95 Participants
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Age, Continuous
41 years
STANDARD_DEVIATION 13 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
Sex: Female, Male
Male
88 Participants
n=5 Participants
Region of Enrollment
Norway
95 participants
n=5 Participants
height
179 cm
STANDARD_DEVIATION 7 • n=5 Participants
BMI
28 kg/m^2
STANDARD_DEVIATION 4 • n=5 Participants
Smoking
Never-smokers
34 participants
n=5 Participants
Smoking
Ex-smokers
22 participants
n=5 Participants
Smoking
Smokers
39 participants
n=5 Participants
duration of exposure
16 years
STANDARD_DEVIATION 13 • n=5 Participants
Spirometry
FVC
5.02 Litres
STANDARD_DEVIATION 0.91 • n=5 Participants
Spirometry
FEV1
3.92 Litres
STANDARD_DEVIATION 0.81 • n=5 Participants
Fraction of exhaled nitric oxide (FeNO)
14 parts per billion
n=5 Participants
Inflammatory markers in blood
IL-1B
0.25 ng/litre
n=5 Participants
Inflammatory markers in blood
IL-10
1.12 ng/litre
n=5 Participants

PRIMARY outcome

Timeframe: baseline and 6-8h

Changes in lung function measurements during one work shift (6-8h), spirometry and gass diffusion capacity

Outcome measures

Outcome measures
Measure
Exposed Workers
n=93 Participants
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Changes in Lung Function Measurements During One Work Shift (6-8h)
FVC
4.99 Litres
Standard Deviation 0.97
Changes in Lung Function Measurements During One Work Shift (6-8h)
FEV1
3.88 Litres
Standard Deviation 0.81

SECONDARY outcome

Timeframe: baseline and 6-8h

Population: Problems With the FeNO (NIOX) device lead to few (58) included in FeNO measurements

Outcome measures

Outcome measures
Measure
Exposed Workers
n=58 Participants
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Changes in FeNO Measurements During One Shift (6-8h)
14 ppb
Interval 0.0 to 98.0

SECONDARY outcome

Timeframe: Baseline and 6-8h

Outcome measures

Outcome measures
Measure
Exposed Workers
n=88 Participants
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Changes in Serum/Plasma Inflammatory Markers During One Shift (6-8h)
IL-10
0.91 ng/Litre
Interval 0.09 to 6.45
Changes in Serum/Plasma Inflammatory Markers During One Shift (6-8h)
IL-1B
0.23 ng/Litre
Interval 0.09 to 3.51

SECONDARY outcome

Timeframe: 0-32h

Outcome measures

Outcome measures
Measure
Exposed Workers
n=58 Participants
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Changes in FeNO Measurements Between Baseline (0h) and 32 h
12 ppb
Interval 0.0 to 82.0

SECONDARY outcome

Timeframe: 0-32h

Outcome measures

Outcome measures
Measure
Exposed Workers
n=88 Participants
95 workers from two cement plants in Norway were included and examined pre and post shift (ohr and 8hr)and again after 24 hours.
Changes in Serum/Plasma Inflammatory Markers Between Baseline and 32 h
IL-1B
0.20 ng/Litre
Interval 0.09 to 3.51
Changes in Serum/Plasma Inflammatory Markers Between Baseline and 32 h
IL-10
0.97 ng/Litre
Interval 0.1 to 4.55

Adverse Events

Exposed Workers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Anne Kristin M. Fell, MD, PhD

Telemark Hospital

Phone: +4735003106

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place